TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/25 16:02 | 3/22/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 4 | 7 | P | 2,708 | 3.79 | 0 | 715 | 12 | 6,552 | D | ||||||||||||||
5/13/25 11:30 | 5/12/25 | NRC | National Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 34 | 13.59 | 0 | 3 | 8 | 35 | D | ||||||||||||||
2/28/25 16:39 | 2/27/25 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1 | 326.00 | 0 | 0 | 0 | 13 | D | ||||||||||||||
2/21/25 16:41 | 2/20/25 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 1,252 | 164.93 | 0 | 8 | 3 | 306 | D | |||||||||||||||
2/7/25 19:03 | 12/3/24 | IQV | Iqvia Holdings Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P.d | 256 | 200.58 | 0 | 1 | 5 | 29 | I | ||||||||||||||
12/23/24 21:47 | 12/19/24 | NOTV | Inotiv, Inc. | IN | Health | Biolab | Commercial Physical & Biologi | 5 | 6 | P | 743 | 4.16 | 0 | 179 | 44 | 588 | D | ||||||||||||||
6/10/24 17:55 | 6/7/24 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P.m | 489 | 4.89 | 0 | 100 | 100 | D | |||||||||||||||
3/5/24 21:30 | 3/1/24 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1,000 | 4.50 | 0 | 222 | 3 | 8,253 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |